SG136072A1 - Tetrahydronaphthalene derivatives, processes for preparing them and their use as antiinflammatory agents - Google Patents

Tetrahydronaphthalene derivatives, processes for preparing them and their use as antiinflammatory agents

Info

Publication number
SG136072A1
SG136072A1 SG200701912-8A SG2007019128A SG136072A1 SG 136072 A1 SG136072 A1 SG 136072A1 SG 2007019128 A SG2007019128 A SG 2007019128A SG 136072 A1 SG136072 A1 SG 136072A1
Authority
SG
Singapore
Prior art keywords
preparing
processes
antiinflammatory agents
tetrahydronaphthalene derivatives
tetrahydronaphthalene
Prior art date
Application number
SG200701912-8A
Other languages
English (en)
Inventor
Markus Berger
Hartmut Rehwinkel
Heike Schacke
Stefan Baurle
Norbert Schmees
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36754173&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG136072(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of SG136072A1 publication Critical patent/SG136072A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C15/00—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
    • C07C15/20—Polycyclic condensed hydrocarbons
    • C07C15/24—Polycyclic condensed hydrocarbons containing two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C07D215/60—N-oxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/02—1,2-Oxazines; Hydrogenated 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans
SG200701912-8A 2006-03-15 2007-03-14 Tetrahydronaphthalene derivatives, processes for preparing them and their use as antiinflammatory agents SG136072A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06090031A EP1834948A1 (fr) 2006-03-15 2006-03-15 Derives de tetrahydronaphtalene , procedes pour leur production et leur utilisation en tant qu'anti-inflammatoires

Publications (1)

Publication Number Publication Date
SG136072A1 true SG136072A1 (en) 2007-10-29

Family

ID=36754173

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200701912-8A SG136072A1 (en) 2006-03-15 2007-03-14 Tetrahydronaphthalene derivatives, processes for preparing them and their use as antiinflammatory agents

Country Status (35)

Country Link
US (2) US7880042B2 (fr)
EP (2) EP1834948A1 (fr)
JP (1) JP2009532337A (fr)
KR (1) KR20080112233A (fr)
CN (1) CN101553472A (fr)
AR (1) AR059896A1 (fr)
AT (1) ATE517092T1 (fr)
AU (1) AU2007224593A1 (fr)
BR (1) BRPI0708860A2 (fr)
CA (1) CA2637597A1 (fr)
CR (1) CR10286A (fr)
CU (1) CU23744B7 (fr)
CY (1) CY1111954T1 (fr)
DK (1) DK1994005T3 (fr)
DO (1) DOP2007000050A (fr)
EA (1) EA015834B1 (fr)
EC (1) ECSP088740A (fr)
ES (1) ES2370176T3 (fr)
GT (1) GT200800182A (fr)
IL (1) IL193155A0 (fr)
MX (1) MX2008011790A (fr)
MY (1) MY146671A (fr)
NO (1) NO20084301L (fr)
NZ (1) NZ570407A (fr)
PA (1) PA8718801A1 (fr)
PE (1) PE20071024A1 (fr)
PL (1) PL1994005T3 (fr)
PT (1) PT1994005E (fr)
SG (1) SG136072A1 (fr)
SI (1) SI1994005T1 (fr)
TW (1) TW200804287A (fr)
UA (1) UA94603C2 (fr)
UY (1) UY30211A1 (fr)
WO (1) WO2007104582A1 (fr)
ZA (1) ZA200808754B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638515B2 (en) * 2003-10-08 2009-12-29 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US7662821B2 (en) 2003-10-08 2010-02-16 Bayer Schering Pharma Ag Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
WO2005034939A1 (fr) * 2003-10-08 2005-04-21 Schering Aktiengesellschaft Derives de tetrahydronaphtalene a substitution 1-amino-2-oxy, procedes pour leur production et leur utilisation en tant qu'anti-inflammatoires
US20080153859A1 (en) * 2004-04-05 2008-06-26 Hartmut Rehwinkel Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US20060084652A1 (en) * 2004-09-09 2006-04-20 Stefan Baeurle Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US20060229305A1 (en) * 2005-03-22 2006-10-12 Markus Berger Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
EP2072509A1 (fr) * 2007-12-18 2009-06-24 Bayer Schering Pharma Aktiengesellschaft 1-aryl-1H-quinoline-2-ones : leur procédé de fabrication et leur utilisation en tant qu'agents anti-inflammatoires
WO2011146610A2 (fr) * 2010-05-19 2011-11-24 Dr. Reddy's Laboratories Ltd. Synthèse énantiosélective d'amines chirales pour la production de rotigotine
JP6115303B2 (ja) * 2012-05-18 2017-04-19 Jnc株式会社 隣接基としてカルボニル基を有するフェノール化合物およびその用途
PL233977B1 (pl) * 2018-01-10 2019-12-31 Politechnika Warszawska Sposób otrzymywania 7-metoksy-1,2,3-tris(4-metoksyfenylo)- 1,2,3,4-tetrahydronaftalenu

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791474A (fr) * 1971-11-25 1973-03-16 Yamanouchi Pharma Co Ltd Procede de preparation de derives d'acides cycloalcoylaminoarylcarboxyliques
JPS63220242A (ja) 1987-03-10 1988-09-13 Fuji Photo Film Co Ltd フオトレジスト組成物
NZ224622A (en) 1987-05-15 1992-06-25 Schering Corp Benzoxepine, benzazepine and benzocycloheptene derivatives and pharmaceutical compositions
US5225436A (en) * 1987-05-15 1993-07-06 Schering Corporation Aryl substituted naphthalene derivatives
ATE145907T1 (de) 1987-07-16 1996-12-15 Byk Gulden Lomberg Chem Fab Imidazo(1,2-a>pyridine
US5059609A (en) * 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
JPH0717589B2 (ja) 1990-01-22 1995-03-01 ファイザー製薬株式会社 新規１，３―ジカルボニル化合物およびその組成物
JPH0641038A (ja) 1992-07-17 1994-02-15 Mitsubishi Kasei Corp カルボン酸誘導体
US5489584A (en) * 1994-12-29 1996-02-06 Allergan, Inc. Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
WO1996020930A1 (fr) 1994-12-29 1996-07-11 Allergan Acetylenes a activite biologique analogue aux retinoides disubstitues par un groupe tetrahydronaphtyle ou dihydronaphtyle substitue 5 ou 8 fois et par des groupes aryles ou heteroaryles
ID22718A (id) * 1997-03-24 1999-12-09 Byk Gulden Lomberg Chem Fab Senyawa-senyawa tetrahidropirido
CA2297906A1 (fr) 1997-07-22 1999-02-04 Bret Eugene Huff Composes pharmaceutiques
GB9716244D0 (en) 1997-07-31 1997-10-08 Electrophoretics International Pharmaceutical compounds
US6333337B1 (en) 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
US7468422B2 (en) * 1998-03-05 2008-12-23 Centre National De La Recherche Scientifique - Cnrs Mechanosensitive mammalian potassium channel activatable by polyunsaturated fatty acids
US6013830A (en) 1998-03-30 2000-01-11 Sepracor Inc. Asymmetric grignard synthesis with cyclic 1,2 aminoalcohols
WO2000010977A1 (fr) 1998-08-21 2000-03-02 The Scripps Research Institute Aminohydroxylation catalytique asymetrique avec des heterocycles a substitution amino
JP2000256255A (ja) 1999-03-10 2000-09-19 Kuraray Co Ltd （±）−トランス−ペルメトリン酸の光学分割法
SE9903930D0 (sv) 1999-10-29 1999-10-29 Astra Pharma Inc Novel compounds and a novel process for their preparation
DE10038639A1 (de) * 2000-07-28 2002-02-21 Schering Ag Nichtsteroidale Entzündungshemmer
AU2001280229B2 (en) 2000-08-21 2006-12-07 Pacific Corporation Novel thiourea derivatives and the pharmaceutical compositions containing the same
ES2193839B1 (es) 2001-06-22 2005-02-16 Almirall Prodesfarma, S.A. Nuevos derivados de 6-fenildihidropirrolpirimidindiona.
US7326731B2 (en) 2001-09-21 2008-02-05 Eli Lilly And Company Muscarinic agonists
AR036608A1 (es) 2001-09-24 2004-09-22 Bayer Corp Derivados de imidazol, composiciones farmaceuticas y el uso de dichos derivados para la fabricacion de un medicamento para el tratamiento de la obesidad
ES2333586T3 (es) 2001-11-21 2010-02-24 PHARMACIA & UPJOHN COMPANY LLC Derivados de aril 1,4-pirazina sustituidos.
US6875866B2 (en) * 2002-02-21 2005-04-05 Schering Corporation Process for synthesis of D1 receptor antagonists
MXPA04009125A (es) 2002-03-21 2004-12-07 Schering Ag Inhibidores de carboxipeptidasa b plasmatica.
US6903215B2 (en) 2002-03-26 2005-06-07 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US6897224B2 (en) * 2002-04-02 2005-05-24 Schering Ag Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
DE10215316C1 (de) 2002-04-02 2003-12-18 Schering Ag Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
EP1532090B1 (fr) 2002-08-26 2010-03-17 MERCK PATENT GmbH Derivates de cyclopenta ¬b naphtaline
EP1583745A1 (fr) 2003-01-03 2005-10-12 Boehringer Ingelheim Pharmaceuticals Inc. Dérivés de 1-propanol et 1-propylamine et leur utilisation en tant que ligands de glucocorticoide
US20040224992A1 (en) 2003-02-27 2004-11-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
AU2004254205A1 (en) 2003-07-01 2005-01-13 Schering Aktiengesellschaft Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents
US20050090559A1 (en) * 2003-07-01 2005-04-28 Markus Berger Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents
WO2005021682A1 (fr) 2003-08-22 2005-03-10 Merck Patent Gmbh Derives de cyclopenta[a]naphthaline
CN1239441C (zh) 2003-09-12 2006-02-01 中国科学院上海有机化学研究所 利用固载化的双辛可尼类生物碱配体催化不对称羟胺化和双羟化反应的方法
WO2005034939A1 (fr) 2003-10-08 2005-04-21 Schering Aktiengesellschaft Derives de tetrahydronaphtalene a substitution 1-amino-2-oxy, procedes pour leur production et leur utilisation en tant qu'anti-inflammatoires
US7638515B2 (en) * 2003-10-08 2009-12-29 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US7662821B2 (en) * 2003-10-08 2010-02-16 Bayer Schering Pharma Ag Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US7179919B2 (en) 2004-03-18 2007-02-20 Boehringer Ingelheim Pharmaceuticals, Inc. Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
US20050222154A1 (en) * 2004-04-05 2005-10-06 Hartmut Rehwinkel Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US20080153859A1 (en) * 2004-04-05 2008-06-26 Hartmut Rehwinkel Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
GB0418045D0 (en) 2004-08-12 2004-09-15 Glaxo Group Ltd Compounds
DE102004044680B3 (de) 2004-09-09 2006-06-08 Schering Ag Alkyliden-Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer sowie diese enthaltende pharmazeutische Präparate
US20060084652A1 (en) * 2004-09-09 2006-04-20 Stefan Baeurle Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
DE102004063227A1 (de) 2004-12-22 2006-07-06 Schering Ag Tricylische Aminoalkohole, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
US20060167025A1 (en) * 2004-12-22 2006-07-27 Markus Berger Tricyclic amino alcohols, processes for synthesis of same and use of same as anti-inflammatory drugs
US20060247292A1 (en) * 2005-03-22 2006-11-02 Hartmut Rehwinkel Benzocycloheptene derivatives, process for their production and their use as anti-inflammatory agents
DE102005014089A1 (de) 2005-03-22 2006-09-28 Schering Ag Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
US20060229305A1 (en) * 2005-03-22 2006-10-12 Markus Berger Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US20070015761A1 (en) * 2005-04-14 2007-01-18 Anne Mengel Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US20070129359A1 (en) * 2005-04-14 2007-06-07 Christoph Huwe Tetrahydronaphthalene derivatives, processes for their preparation and their use as antiinflammatory agents
WO2006108699A1 (fr) 2005-04-14 2006-10-19 Glaxo Group Limited Indazoles en tant que ligands de recepteur glucocorticoide
DE102005017286B3 (de) 2005-04-14 2006-12-28 Schering Ag Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
US20070015750A1 (en) * 2005-04-14 2007-01-18 Stefan Baeurle Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
JP4980366B2 (ja) * 2005-12-09 2012-07-18 エフ．ホフマン−ラ ロシュ アーゲー 抗炎症剤としてのグルココルチコイド受容体モジュレーター

Also Published As

Publication number Publication date
ATE517092T1 (de) 2011-08-15
CR10286A (es) 2008-10-29
CY1111954T1 (el) 2015-11-04
EP1994005B1 (fr) 2011-07-20
IL193155A0 (en) 2009-02-11
US20100298311A1 (en) 2010-11-25
WO2007104582A1 (fr) 2007-09-20
PE20071024A1 (es) 2007-12-13
DOP2007000050A (es) 2007-09-30
KR20080112233A (ko) 2008-12-24
JP2009532337A (ja) 2009-09-10
US20070225290A1 (en) 2007-09-27
MX2008011790A (es) 2008-09-25
PL1994005T3 (pl) 2012-01-31
NZ570407A (en) 2010-08-27
EA015834B1 (ru) 2011-12-30
CN101553472A (zh) 2009-10-07
CA2637597A1 (fr) 2007-09-20
CU23744B7 (es) 2012-01-31
AR059896A1 (es) 2008-05-07
BRPI0708860A2 (pt) 2011-06-14
EP1994005B9 (fr) 2012-01-11
EP1834948A1 (fr) 2007-09-19
TW200804287A (en) 2008-01-16
MY146671A (en) 2012-09-14
ECSP088740A (es) 2008-10-31
GT200800182A (es) 2009-08-20
ES2370176T3 (es) 2011-12-13
PT1994005E (pt) 2011-10-20
UY30211A1 (es) 2007-10-31
NO20084301L (no) 2008-12-12
ZA200808754B (en) 2009-12-30
SI1994005T1 (sl) 2011-11-30
EP1994005A1 (fr) 2008-11-26
DK1994005T3 (da) 2011-11-21
CU20080169A7 (es) 2011-02-24
UA94603C2 (ru) 2011-05-25
EA200801893A1 (ru) 2009-04-28
US7880042B2 (en) 2011-02-01
PA8718801A1 (es) 2009-04-23
AU2007224593A1 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
SG136072A1 (en) Tetrahydronaphthalene derivatives, processes for preparing them and their use as antiinflammatory agents
IL238438A (en) 2,2,2-trifluoroacetophenones and a method for preparing them
EP2151500A4 (fr) -glucan ramifié, -glucosyltransférase produisant celui-ci, son procédé de fabrication et son utilisation
IL214183A (en) Pharma-informatics system and method, preparation for use with it and method for preparation of the preparation
IL220816A0 (en) Process for preparing cell-binding agent-cytotoxic agent
MY147394A (en) Pyridonecarboxamides, crop protection agents containing the same, method for production and use thereof
ZA200805939B (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
EP2198962A4 (fr) Catalyseur, son procédé de fabrication et son utilisation
IL204555A0 (en) (carboxylalkylene-phenyl) phenyl-oxalamides, method for the production thereof, and use of same as a medicatment
IL182919A0 (en) Process for preparing telmisartan and telmisartan derivatives prepared thereby
GB0616111D0 (en) Agents, methods and uses
HUP0500920A2 (en) Oxadiazole derivatives, process for their preparation and their use
SI2234979T1 (sl) 5-((3,3,3-trifluoro-2-hidroksi-1-arilpropil)amino)-1H-kinolin-2-oni, postopek njihove proizvodnje in njihova uporaba kot protivnetna sredstva
GB0613674D0 (en) Derivatives of urea and related diamines, methods for their manufacture, and uses therefor
HUP0500921A2 (en) Tetrazole derivatives, process for their preparation and their use
IL181832A0 (en) Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents
HUP0600668A2 (en) Active carrier, process for producing thereof and the use of thereof
EP2121601B8 (fr) Nouveaux derives indoliques, leurs procedes de preparation et leurs utilisations notamment en tant qu'antibacteriens
IL194581A (en) Procindiphosphines, a process for their preparation, complexes of transition metals containing them, and uses in the preparation of organic compounds
IL190596A0 (en) 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
ZA201000520B (en) Substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments
IL201444A0 (en) New 4, 8 - diphenyl - polyazanaphthalene derivatives
ZA201004272B (en) An improved process for the preparation of trans 3,4-diarylchroman and their derivatives
ZA201003264B (en) Method for the preparation of 2 chloro1,1,1,2,3,3,3 heptafluopropane
GB0600213D0 (en) 2,6-quinolinyl derivatives, processes for preparing them and their uses